Please login to the form below

Not currently logged in
Email:
Password:

James D'Arecca joins Actavis

Moves from Bausch & Lomb to take up accounting role

James D'Arecca has moved from eyecare firm Bausch & Lomb to join generic company Actavis as its new chief accounting officer.

He served in a similar role at Bausch & Lomb and in his new position will report to Actavis' chief financial officer R Todd Joyce.

Prior to Bausch & Lomb, he worked for Merck & Co, where he served as executive director and business development controller.

In this role, he was the primary liaison between the controller's organisation and the business development and corporate licensing functions.

Prior to joining Merck, D'Arecca was executive director and assistant controller at Schering-Plough, which Merck acquired in 2009.

His career to date has also included 13 years with PricewaterhouseCoopers, where his industry focus was on pharmaceuticals, medical devices and consumer products.

20th August 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics